Arecor Therapeutics Income Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Revenue	5.05	4.57	2.4	1.16	1.7	Upgrade
Revenue Growth (YoY)	10.50%	90.30%	107.51%	-31.80%	-10.21%	Upgrade
Cost of Revenue	3.51	3.32	-	-	-	Upgrade
Gross Profit	1.54	1.25	2.4	1.16	1.7	Upgrade
Selling, General & Admin	6.18	6.17	5.38	2.39	1.64	Upgrade
Research & Development	3.04	5.4	8.61	5.39	3.94	Upgrade
Other Operating Expenses	-0.27	-1.14	-1.25	-0.64	-0.45	Upgrade
Operating Expenses	8.95	10.43	12.74	7.14	5.13	Upgrade
Operating Income	-7.41	-9.18	-10.34	-5.98	-3.43	Upgrade
Interest Expense	-0.02	-0.02	-0.02	-0.02	-0.08	Upgrade
Interest & Investment Income	0.1	0.28	0.11	0	0	Upgrade
Other Non Operating Income (Expenses)	-	0.01	-	-	-0.01	Upgrade
EBT Excluding Unusual Items	-7.33	-8.9	-10.25	-6	-3.51	Upgrade
Merger & Restructuring Charges	-	-	-0.17	-	-	Upgrade
Impairment of Goodwill	-1.48	-	-	-	-	Upgrade
Asset Writedown	-1.8	-	-	-	-	Upgrade
Other Unusual Items	-	-	-	-0.95	-	Upgrade
Pretax Income	-10.62	-8.9	-10.42	-6.95	-3.51	Upgrade
Income Tax Expense	-0.38	-0.35	-1.16	-0.78	-0.76	Upgrade
Net Income	-10.24	-8.55	-9.26	-6.17	-2.75	Upgrade
Net Income to Common	-10.24	-8.55	-9.26	-6.17	-2.75	Upgrade
Shares Outstanding (Basic)	33	31	29	23	16	Upgrade
Shares Outstanding (Diluted)	33	31	29	23	16	Upgrade
Shares Change (YoY)	9.20%	5.83%	25.63%	41.77%	3.04%	Upgrade
EPS (Basic)	-0.31	-0.28	-0.32	-0.27	-0.17	Upgrade
EPS (Diluted)	-0.31	-0.28	-0.32	-0.27	-0.17	Upgrade
Free Cash Flow	-9.18	-5.99	-11.08	-5.52	-1.91	Upgrade
Free Cash Flow Per Share	-0.27	-0.20	-0.38	-0.24	-0.12	Upgrade
Gross Margin	30.54%	27.36%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-146.63%	-200.63%	-430.34%	-516.15%	-201.88%	Upgrade
Profit Margin	-202.57%	-187.05%	-385.35%	-532.73%	-162.07%	Upgrade
Free Cash Flow Margin	-181.63%	-131.03%	-461.05%	-476.60%	-112.43%	Upgrade
EBITDA	-7.1	-8.88	-10.14	-5.9	-3.34	Upgrade
EBITDA Margin	-140.47%	-194.18%	-	-	-196.70%	Upgrade
D&A For EBITDA	0.31	0.3	0.2	0.08	0.09	Upgrade
EBIT	-7.41	-9.18	-10.34	-5.98	-3.43	Upgrade
EBIT Margin	-146.63%	-200.63%	-	-	-201.88%	Upgrade

Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.